Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Mar 29, 2018 10:22am
219 Views
Post# 27802039

RE:double jeopardy!

RE:double jeopardy!How often do you get a chance to more than double your money on an FDA (mere) delay? The clinical history is 100% success rate in all patients!! How often do you get to see that in FDA trials? This is an opportunity - not a tragedy! Buy now and prosper. IMHO the risk here is phenomenally low for a greater than double in just some months down the road. Too much potential here to dump now. IMHO the approval is a sure thing down the road some months (not to mention 4050) with 100% clinical success. No other ending here is possible !
Bullboard Posts